REPUBLIC OF KOREA (MANAGEMENT;ANIMAL AND PLANT QUARANTINE AGENCY)
发明人:
KANG, SEUNG WON,강승원,CHOI, SE EUN,최세은,NOH, JIN HYEONG,노진형,KWEON, CHANG HEE,권창희,KOH, KYUNG BONG,고경봉
申请号：
KR1020110145900
公开号：
KR1020130077278A
申请日:
2011.12.29
申请国别(地区):
KR
年份:
2013
代理人:
摘要：
PURPOSE: A composition for toxoplasma strongylosis prevention and treatment is provided to be used on the toxoplasma strongylosis prevention and treatment by lowering infection and removing toxoplasma strongylosis without concern for toxicity and antibiotic resistance.CONSTITUTION: A composition for toxoplasma strongylosis prevention and treatment comprises an immunoglobulin yolk obtained through inoculating the toxoplasma strongylosis antigen to an egg. The antigen comprises an additional adjuvant. The immunoglobulin yolk is included to 260-1350 micrograms/milliliters. The treatment method is to inoculate the composition containing pharmaceutically effective amount of immunoglobulin yolk to a mammal.COPYRIGHT KIPO 2013[Reference numerals] (AA) Survival rate (%)본 톡소플라즈마 원충 항원액을 산란계에 접종하여 얻어지는 난황항체를 포함하는 것을 특징으로 하는 톡소플라즈마 원충증 예방 및 치료용 약학 조성물에 관한 것이다.
